Ad
related to: point of care testing log
Search results
Results From The WOW.Com Content Network
Therefore, multiplexed point-of-care testing (xPOCT) has become more important for medical diagnostics in the last decade. [11] Many point-of-care test systems are realized as easy-to-use membrane-based test strips, often enclosed by a plastic test cassette. [2]
An analyte is a substance, chemical or biological, that is being analyzed using a certain instrument. While point-of-care testing is the quantification of one analyte from one in vitro (e.g., blood, plasma or urine) sample, multiplexed point-of-care testing is the simultaneous on-site quantification of various analytes from a single sample. [2]
Point of care (POC) documentation is the ability for clinicians to document clinical information while interacting with and delivering care to patients. [10] The increased adoption of electronic health records (EHR) in healthcare institutions and practices creates the need for electronic POC documentation through the use of various medical devices. [11]
Flow-through tests or immunoconcentration assays [1] are a type of diagnostic assay that allows users to test for the presence of a biomarker, usually a specific antibody, in a sample such as blood. They are a type of point of care test, designed to be used by a healthcare provider at patient contact. Point of care tests often allow for rapid ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Alere Inc. was a global manufacturer of rapid point-of-care diagnostic tests.The company was founded in 1991 and was headquartered in Waltham, Massachusetts. [2] [3] As of January 2017, the company had a market capitalization of $3.47 billion with an enterprise value of $5.9 billion. [1]
Discover the best free online games at AOL.com - Play board, card, casino, puzzle and many more online games while chatting with others in real-time.
However, current testing methods require days to weeks before results are available limiting the clinical applicability of genetic testing in a number of circumstances. Recently, the first point-of-care genetic test in medicine was demonstrated to be effective in identifying CYP2C19 *2 carriers allowing tailoring of anti-platelet regimens to ...
Ad
related to: point of care testing log